/PRNewswire/ DelveInsight s Gastric Cancer Pipeline Insight – 2022 report provides comprehensive global coverage of available, marketed, and pipeline.
/PRNewswire/ Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies long-term.
Triumvira Immunologics ("Triumvira"), a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients
/PRNewswire/ InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on "Global Novel T-Cell Immunotherapies Market– Industry.